TRAIN-HEART Network

The TRAIN-HEART consortium, funded by the European Commission (2019-2023), is made up to train a league of 15 promising fellows that harness novel insights in the pathogenesis of ischemic heart failure, study the therapeutic potential of existing RNA therapeutics and improve its efficacy by the design of novel drug delivery systems.


People

TRAIN-HEART brings together leading academic teams and (biotech) companies covering various disciplines ranging from fundamental research to clinical pharmacology and gene therapy to drug delivery applications, have teamed up in the European Union.


Research Programme

The TRAIN-HEART network aims to gain viable insight in the pathogenesis of ischemic heart failure which will serve as a basis for drug discovery and drug delivery efforts that aim to therapeutically target specific molecules and mechanisms within cardiomyocytes for the treatment of ischemic heart failure.  


Contact

If you have any questions you can fill in the form or mail us directly: info@train-heart.eu.





News

JMCC-ISHR Cardiovascular Webinar - Cardiac Epigenetics Special Issue 12 July 2021

Join the ISHR webinar on the Journal of Molecular and Cellular Cardiology's Special Issue on Cardiac Epigenetics: Driving signals to the cardiac epigenome in development and disease. Guest Editors Emma Louise Robinson, Manuel Rosa-Garrido, Chukwuemeka George Anene-Nzelu will host the discussion with two authors from the special issue: Ralf Gilsbach and Justus Stenzig.


See all articles in this special issue at

https://www.sciencedirect.com/journal/journal-of-molecular-and-cellular-cardiology/special-issue/10MGD9M71M5


Speakers:

Dr Ralf Gilsbach

Dr Justus Stenzig

Chairs:

Dr. Emma Louise Robinson

Dr. Manuel Rosa-Garrido

Dr. Chukwuemeka George Anene-Nzelu

Host: Dr Ronald Vagnozzi


Jul 12, 2021 11:00 AM in Eastern Time (US and Canada)

Webinar registration: https://us02web.zoom.us/webinar/register/WN_dhSNb-MwTJeAI-vdOw6tFA